Shannon K. McWeeney, Ph.D.
Affiliations: | University of California, Berkeley, Berkeley, CA, United States |
Area:
Diabetes, Population Genetics, HLAGoogle:
"Shannon McWeeney"Parents
Sign in to add mentor| Glenys Thomson | grad student | 2000 | UC Berkeley | |
| (Analysis of genetic variation in the major histocompatibility complex region with implications for structural and disease studies.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Burkhart JG, Wu G, Song X, et al. (2023) Biology-inspired graph neural network encodes reactome and reveals biochemical reactions of disease. Patterns (New York, N.Y.). 4: 100758 |
| Noll KE, Whitmore AC, West A, et al. (2020) Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross. Cell Reports. 31: 107587 |
| Joshi SK, Qian K, Bisson WH, et al. (2020) Discovery and Characterization of Targetable NTRK Point Mutations in Hematologic Neoplasms. Blood |
| Modak RV, Damnernsawad A, Laderas T, et al. (2020) Abstract 5942: An integrated approach reveals novel extrinsic pathways and cytokine signatures associated with drug response in acute myeloid leukemia Immunology. 80: 5942-5942 |
| Braun TP, Okhovat M, Coblentz C, et al. (2019) Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia. Nature Communications. 10: 5455 |
| Tyner JW, Bottomly D, Wilmot B, et al. (2019) What do functional genomics tell us about pathogenesis of AML? Best Practice & Research. Clinical Haematology. 32: 101101 |
| Moshofsky KB, Cho HJ, Wu G, et al. (2019) Acute myeloid leukemia-induced T-cell suppression can be reversed by inhibition of the MAPK pathway. Blood Advances. 3: 3038-3051 |
| Luo X, Feurstein S, Mohan S, et al. (2019) ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants. Blood Advances. 3: 2962-2979 |
| Choonoo G, Blucher AS, Higgins S, et al. (2019) Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma. Plos One. 14: e0223639 |
| Blucher AS, McWeeney SK, Stein L, et al. (2019) Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz. F1000research. 8: 908 |